Reports Q4 revenue $105.69B, consensus $103.57B. The company said, “Our fourth quarter and full-year results demonstrate the progress we are making in transforming the health care experience with our unique collection of businesses. From lowering drug prices, to improving navigation of health care, to being the front door of care across our country, we are well positioned to achieve our ambition to be the most trusted health care company in America.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- CVS, ELV, CNC: Health Insurer Stocks Under Pressure as U.S. Expands Fraud Probe
- Is CVS Health Stock (CVS) a Buy Ahead of Q4 Earnings?
- Subpoenas issued to eight health insurers by House panel, Axios reports
- Notable companies reporting before tomorrow’s open
- Trump Trade: White House explores antitrust probe into homebuilders